increasing resection rates pancreatic tumors decreasing postoperative mortality rates specialised centres let arise question additional benefit adjuvant therapy despite extended radical surgery recurrence rates resection pancreatic cancer remain high studies indicated radiosensitivity tumors combined radiochemotherapy recommended actually answered adjuvant radiotherapy inferior combined radiochemotherapy intraoperative radiotherapy preoperative radiotherapy superior postoperative percutaneous radiotherapy regarding recurrence rate survival preoperative radiotherapy preferably combination chemotherapy considered patients non resectable borderline resectable pancreatic tumors aim downstaging secondary resection preliminary results regional adjuvant chemotherapy impressing need confirmed randomised studies overall availability good optimal adjuvant therapy pancreatic cancer far away surgeons need encouraged include patients resected pancreatic carcinoma current study protocol adjuvant treatment tenacious multicentric research lead progress severe disease references NUMBER chemo combination chemotherapy